Live feed06:26:00·35dPRReleasevia QuantisnowCHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast CancerByQuantisnow·Wall Street's wire, on your screen.GILD· Gilead Sciences Inc.Health Care
